Evidence map›Paper›PMID 31410514›Full record

Trial reportWorld journal of surgery2019

Comparison Between the Protector™ Laryngeal Mask Airway and the Endotracheal Tube for Minimally Invasive Thyroid and Parathyroid Surgery.

Georgios Kotsovolis, Ioannis Pliakos, Stavros Panidis, Dimitrios Gkinas, Theodosios Papavramidis

Registry-linked trialAbstract readComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in World journal of surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03098667 (Study of the Laryngopharyngeal Symptoms After Minimally Invasive Thyroidectomy), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03098667 nacompletednot on this map

Study of the Laryngopharyngeal Symptoms After Minimally Invasive Thyroidectomy: Comparison Between the Protector Laryngeal Mask Airway and the Endotracheal Tube.

TypeinterventionalSponsor424 General Military HospitalRan2017 to 2017Enrolled79ConditionsSore Throat, Dysphagia, Postoperative PainArmsLMA Protector, Endotracheal tube
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Georgios KotsovolisDepartment of Anesthesia, 424 Army General Hospital, Thessaloniki, Greece. gskotsos@gmail.com.ORCID 0000-0003-4376-8995
Ioannis Pliakos1st Propedeutic Department of Surgery, AHEPA University Hospital, Thessaloniki, Greece.
Stavros Panidis1st Propedeutic Department of Surgery, AHEPA University Hospital, Thessaloniki, Greece.
Dimitrios GkinasDepartment of Anesthesia and Intensive Care, AHEPA University Hospital, Thessaloniki, Greece.
Theodosios Papavramidis1st Propedeutic Department of Surgery, AHEPA University Hospital, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPharyngolaryngeal symptoms are a main concern after neck surgery. The Protector™ LMA is a new supraglottic airway device. The main purpose of this study was to evaluate whether application of the LMA Protector™ causes fewer pharyngolaryngeal symptoms than application of the endotracheal tube after minimally invasive total thyroidectomy and parathyroidectomy.

methodsThis prospective, randomized controlled trial involved one university and one private practice clinic, during the period from January 2017 until November 2017. The patients were randomly allocated to two groups: ETT and LMA. Main outcomes were Numerical Rating Scale scores of postoperative dysphagia, pharyngodynia, and incisional pain. Secondary outcomes were the frequency of rescue analgesia (paracetamol) consumption and emergence cough. Data were recorded in the post-anesthesia care unit and at 1, 6, 12, and 24 h after surgery.

resultsData from 78 patients were included in the final analysis. Pharyngodynia scores were significantly lower in the LMA group, compared with the ETT group, at 1 h, 6 h and 12 h after surgery. Dysphagia and surgical incision pain scores were also significantly lower in the LMA group, compared with the ETT group, at 6 h and 12 h after surgery. The frequency of postoperative paracetamol consumption was significantly increased in the ETT group, compared with the LMA group. Finally, the LMA group had fewer episodes of emergence cough, compared with the ETT group.

conclusionThe LMA Protector™ causes fewer pharyngolaryngeal symptoms than the ETT within 6 and 12 h after minimally invasive total thyroidectomy and parathyroidectomy.

trial registrationClinicalTrials.gov Identifier NCT03098667.

Indexed as

AcetaminophenAdultAgedAnalgesics, Non-NarcoticCoughDeglutition DisordersFemaleHumansIntubation, IntratrachealLaryngeal MasksMaleMiddle AgedMinimally Invasive Surgical ProceduresParathyroidectomyPostoperative PainPostoperative PeriodAcetaminophenAnalgesics, Non-Narcotic

Identifiers

PMID31410514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.